Related Experiment Video
Updated: Aug 21, 2026

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
Inhibition of transcription factor activity by nuclear compartment-associated Bcl-2
Cynthia A Massaad1, Bryce P Portier, Giulio Taglialatela
1Department of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, Texas 77555-1043, USA.
Abstract:
Using a reporter gene assay in PC12, HEK293, HeLa, and NIH-3T3 cells, we show that the anti-apoptotic protein Bcl-2 significantly inhibits transcriptional activation of various transcription factors, including NF kappa B, AP1, CRE, and NFAT. A Bcl-2 mutant lacking its BH4 domain (Delta BH4) also inhibited transcription, whereas a Bcl-2 mutant lacking its transmembrane domain (Delta TM) was ineffective. Furthermore, Bcl-2 chimeric proteins containing transmembrane domains from the mitochondrial protein monoamine oxidase B (MaoB) or the endoplasmic reticulum protein cytochrome b(5) showed no effect on transcription factor activity. Subcellular localization studies showed that under conditions of transient transfection, the active Bcl-2 forms (wild type and Delta BH4) were predominantly found in the nuclear fraction, whereas the non-active forms (Delta TM, MaoB, and cytochrome b(5)) were in the non-nuclear fraction. Additionally, stably expressed Bcl-2 loses its ability to inhibit transcriptional activation and localizes predominantly to the non-nuclear fraction. Expression of FKBP38 (a chaperone that shuttles Bcl-2 to the mitochondria) removes co-expressed Bcl-2 from the nuclear fraction and reverses its effect on transcription factor activity. Finally, using an inducible gene expression system, we show that nuclear compartment-associated Bcl-2 prevents entry of NF kappa B subunits to the nucleus without affecting NF kappa B release from its cytosolic inhibitory sub-unit I kappa B alpha. These results suggest that (a) Bcl-2 suppresses transcriptional activity of multiple transcription factors; (b) Bcl-2 does not interfere with NF kappa B activation but prevents entrance of its active subunits to the nucleus; (c) membrane anchoring is required for this function of Bcl-2; and (d) association of Bcl-2 with the nuclear compartment is also necessary. We speculate that nuclear compartment-associated Bcl-2 may affect nuclear trafficking of multiple factors necessary for transcriptional activity.
Insights
The anti-apoptotic protein Bcl-2 inhibits multiple transcription factors by preventing nuclear entry of NF-kappa B subunits. This nuclear localization and membrane anchoring are crucial for Bcl-2
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The anti-apoptotic protein Bcl-2 is known for its role in preventing programmed cell death.
- Its non-apoptotic functions, particularly in regulating gene transcription, are less understood.
- Understanding Bcl-2's extramitochondrial roles is crucial for a comprehensive view of its cellular functions.
Purpose of the Study:
- To investigate the role of Bcl-2 in regulating transcriptional activation of various transcription factors.
- To determine the specific domains and cellular localization of Bcl-2 required for this function.
- To elucidate the mechanism by which Bcl-2 affects transcription factor activity, specifically NF-kappa B.
Main Methods:
- Reporter gene assays in multiple cell lines (PC12, HEK293, HeLa, NIH-3T3) to measure transcriptional activity.
- Analysis of Bcl-2 mutants (lacking BH4 or transmembrane domains) and chimeric proteins.
- Subcellular localization studies using transient and stable expression systems, including FKBP38 co-expression.
- Inducible gene expression system to study NF-kappa B nuclear translocation.
Main Results:
- Bcl-2 significantly inhibits transcriptional activation of NF-kappa B, AP1, CRE, and NFAT.
- The BH4 domain is important, but the transmembrane domain is essential for Bcl-2's inhibitory function.
- Active Bcl-2 forms localize to the nucleus, while inactive forms are non-nuclear; stable expression leads to non-nuclear localization and loss of function.
- Nuclear Bcl-2 prevents NF-kappa B subunit entry into the nucleus without affecting I kappa B alpha degradation.
Conclusions:
- Bcl-2 suppresses the transcriptional activity of multiple transcription factors.
- Nuclear localization and membrane anchoring of Bcl-2 are necessary for its function in inhibiting transcription factor activity.
- Bcl-2 regulates NF-kappa B pathway by blocking nuclear translocation of its subunits, suggesting a role in nuclear trafficking regulation.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
The Intrinsic Apoptotic Pathway
Co-activators and Co-repressors
Co-activators and Co-repressors
RNA Polymerase II Accessory Proteins
Regulation of Nuclear Protein Sorting

